This inventor holds 1 USPTO granted patent. Top assignee: Baylor University. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: J Freeland Ackley: Innovator in Cysteine Protease Inhibition
Introduction
J Freeland Ackley is a notable inventor based in Erie, PA (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for cysteine proteases. His work aims to address critical health issues related to protozoan infections and cancer.
Latest Patents
Ackley's most recent patent is titled "Inhibitors of cysteine proteases and methods of use thereof." This invention focuses on semicarbazone or thiosemicarbazone inhibitors that target cysteine proteases. These compounds are designed to prevent and treat protozoan infections such as trypanosomiasis, malaria, and leishmaniasis. Additionally, they are useful in inhibiting cysteine proteases associated with carcinogenesis, including cathepsins B and L. Ackley holds 1 patent for this innovative work.
Career Highlights
J Freeland Ackley is affiliated with Baylor University, where he continues to advance research in his field. His academic and professional journey has been marked by a commitment to developing solutions for pressing health challenges.
Collaborations
Ackley has collaborated with esteemed colleagues, including Rogelio Siles and Ming Zhou, to further enhance the impact of his research.
Conclusion
J Freeland Ackley's contributions to the field of cysteine protease inhibition represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments for serious diseases.